Q4 2021 Pharming Group NV Earnings Call Transcript
Good evening or good afternoon, ladies and gentlemen. Welcome to the Pharming Group full year results webinar out of Amsterdam here.
And for those of you who join us for the first time, my name is Sijmen de Vries, and I'm the CEO of Pharming. And I'm here together with my colleague, our Chief Financial Officer, Jeroen Wakkerman, and we will present and then present some questions that we have received.
But before we do that, I would like to draw your attention to this safe harbor slide, safe harbor statement about forward-looking statements because this presentation may contain or we will be making probably forward-looking statements, which are, of course, based upon our current beliefs, plans and expectations, and those obviously can change towards the future.
So without further ado, I would like to start the presentation. We are in a very special situation at this point in time. For the second time in the history of our company, we are actually in possession of positive pivotal trial data for one
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |